Dentsply Sirona (XRAY) announced the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the company conducts a review of certain regulatory requirements related to these products. The company’s decision was made in consultation with the FDA. The company has suspended shipment and processing of new and recently placed orders for Byte Aligners and Impression Kits. The state regulatory environment has adversely impacted the Byte Aligner business model, resulting in declining conversion rates, and new documentation, records and additional requirements. As a result, the company had begun to assess resources at Byte to leverage and/or redeploy infrastructure, talent, and capability elsewhere in its business.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY: